SciClone Pharma ups earnings guidance after Q3 results

|About: SciClone Pharmaceuticals, ... (SCLN)|By:, SA News Editor

SciClone Pharmaceuticals (SCLN +1.7%) Q3 results: Revenues: $34.3M (-2.6%); COGS: $6M (+57.9%); R&D Expense: $0.7M (+16.7%); SG&A: $19.5M (-21.1%); Operating Income: $8.1M (+32.8%); Net Income: $7.9M (-9.2%); EPS: $0.15 (-6.3%); Quick Assets: $96.9M (12.8%).

2014 Guidance: Revenue: $130M - 135M (unch); non-GAAP EPS: $0.64 - 0.68 from $0.51 - 0.57.

Subscribe for full text news in your inbox